These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9576283)

  • 61. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma.
    Choi J; Kim GA; Han S; Lee W; Chun S; Lim YS
    Hepatology; 2019 May; 69(5):1983-1994. PubMed ID: 30153338
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel method to measure serum levels of des-gamma-carboxy prothrombin for hepatocellular carcinoma in patients taking warfarin: a preliminary report.
    Toyoda H; Kumada T; Osaki Y; Tada T; Kaneoka Y; Maeda A
    Cancer Sci; 2012 May; 103(5):921-5. PubMed ID: 22320249
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.
    Kim SU; Park JH; Kim HS; Lee JM; Lee HG; Kim H; Choi SH; Baek S; Kim BK; Park JY; Kim DY; Ahn SH; Lee JD; Han KH
    Yonsei Med J; 2015 Sep; 56(5):1296-306. PubMed ID: 26256972
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma.
    Sugimoto H; Takeda S; Inoue S; Kaneko T; Watanabe K; Nakao A
    Liver Int; 2003 Feb; 23(1):38-44. PubMed ID: 12640726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum monomeric laminin-γ2 as a novel biomarker for hepatocellular carcinoma.
    Kiyokawa H; Yasuda H; Oikawa R; Okuse C; Matsumoto N; Ikeda H; Watanabe T; Yamamoto H; Itoh F; Otsubo T; Yoshimura T; Yoshida E; Nakagawa M; Koshikawa N; Seiki M
    Cancer Sci; 2017 Jul; 108(7):1432-1439. PubMed ID: 28418226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3.
    Volk ML; Hernandez JC; Su GL; Lok AS; Marrero JA
    Cancer Biomark; 2007; 3(2):79-87. PubMed ID: 17522429
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Study on the value of serum des-γ-carboxy prothrombin in predicting hepatocellular carcinoma recurrence after liver transplantation].
    Xu Y; Wang PX; Cheng JW; Huang XW; Zhou J; Fan J; Yang XR
    Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):918-923. PubMed ID: 33256276
    [No Abstract]   [Full Text] [Related]  

  • 70. Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma.
    Song BC; Chung YH; Kim JA; Choi WB; Suh DD; Pyo SI; Shin JW; Lee HC; Lee YS; Suh DJ
    Cancer; 2002 Jan; 94(1):175-80. PubMed ID: 11815974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of des-gamma-carboxy prothrombin levels in hepatocellular carcinoma and liver tissues.
    Shimada M; Yamashita Y; Hamatsu T; Hasegawa H; Utsunomiya T; Aishima S; Sugimachi K
    Cancer Lett; 2000 Oct; 159(1):87-94. PubMed ID: 10974410
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnostic performance of des-γ-carboxy prothrombin (DCP) for hepatocellular carcinoma: a bivariate meta-analysis.
    Gao P; Li M; Tian QB; Liu DW
    Neoplasma; 2012; 59(2):150-9. PubMed ID: 22248272
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma.
    Nagaoka S; Yatsuhashi H; Hamada H; Yano K; Matsumoto T; Daikoku M; Arisawa K; Ishibashi H; Koga M; Sata M; Yano M
    Cancer; 2003 Dec; 98(12):2671-7. PubMed ID: 14669288
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
    Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
    Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study.
    Ette AI; Ndububa DA; Adekanle O; Ekrikpo U
    BMC Gastroenterol; 2015 Sep; 15():113. PubMed ID: 26341083
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Half-Life of Serum Des-Gamma-Carboxy Prothrombin Is a Prognostic Index of Survival and Recurrence After Liver Resection for Hepatocellular Carcinoma.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):921-928. PubMed ID: 27638677
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma.
    Kuromatsu R; Tanaka M; Shimauchi Y; Shimada M; Tanikawa K; Watanabe K; Yokoo T
    J Gastroenterol; 1997 Aug; 32(4):507-12. PubMed ID: 9250899
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical evaluation of plasma abnormal prothrombin (des-gamma-carboxy prothrombin) in hepatobiliary malignancies and other diseases.
    Nakao A; Suzuki Y; Isshiki K; Kimura Y; Takeda S; Kishimoto W; Nonami T; Harada A; Takagi H
    Am J Gastroenterol; 1991 Jan; 86(1):62-6. PubMed ID: 1702578
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C.
    Sterling RK; Wright EC; Morgan TR; Seeff LB; Hoefs JC; Di Bisceglie AM; Dienstag JL; Lok AS
    Am J Gastroenterol; 2012 Jan; 107(1):64-74. PubMed ID: 21931376
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.
    Weitz IC; Liebman HA
    Hepatology; 1993 Oct; 18(4):990-7. PubMed ID: 8406374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.